Biolife Solutions Inc’s recent filing unveils that its EVP & Chief Scientific Officer Mathew Aby J. unloaded Company’s shares for reported $2442.0 on Feb 12 ’25. In the deal valued at $26.54 per share,92 shares were sold. As a result of this transaction, Mathew Aby J. now holds 262,623 shares worth roughly $6.6 million.
Then, Wichterman Troy sold 159 shares, generating $4,220 in total proceeds. Upon selling the shares at $26.54, the Chief Financial Officer now owns 121,620 shares.
Before that, Foster Karen A. sold 78 shares. Biolife Solutions Inc shares valued at $2,070 were divested by the Chief Quality and Operations at a price of $26.54 per share. As a result of the transaction, Foster Karen A. now holds 156,567 shares, worth roughly $3.93 million.
H.C. Wainwright initiated its Biolife Solutions Inc [BLFS] rating to a Buy in a research note published on September 30, 2024; the price target was $29. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Craig Hallum began covering BLFS with “Buy” recommendation on July 11, 2023. Oppenheimer revised its rating on April 25, 2022. It rated BLFS as “an Outperform” which previously was an “a Perform”.
Price Performance Review of BLFS
On Tuesday, Biolife Solutions Inc [NASDAQ:BLFS] saw its stock fall -2.29% to $25.13. Over the last five days, the stock has lost -11.26%. Biolife Solutions Inc shares have fallen nearly -3.20% since the year began. Nevertheless, the stocks have risen 41.26% over the past one year. While a 52-week high of $29.55 was reached on 01/30/25, a 52-week low of $14.50 was recorded on 02/25/25. SMA at 50 days reached $26.86, while 200 days put it at $24.17.
Levels Of Support And Resistance For BLFS Stock
The 24-hour chart illustrates a support level at 24.58, which if violated will result in even more drops to 24.04. On the upside, there is a resistance level at 25.78. A further resistance level may holdings at 26.44. The Relative Strength Index (RSI) on the 14-day chart is 38.10, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.90, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.60%. Stochastics %K at 20.70% indicates the stock is a holding.
The most recent change occurred on October 19, 2021 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $61 price target.
